Published in

American Diabetes Association, Diabetes, 7(67), p. 1414-1427, 2018

DOI: 10.2337/db17-0914

Links

Tools

Export citation

Search in Google Scholar

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

Journal article published in 2018 by Natalie R. van Zuydam, Warren 3. and Genetics of Kidneys in Diabetes (GoKinD) Study Group, N. R. Van Zuydam, N. William Rayner, Neil R. Robertson, N. William Rayner, M. Loredana Marcovecchio ORCID, Warren, E. Shyong Tai, Paul M. McKeigue, Rob M. van Dam, Valma Harjutsalo, Annalisa Perna, Erica Rurali, Marcovecchio Ml and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS) of DKD in type 2 diabetes (T2D) using eight complementary dichotomous and quantitative DKD phenotypes: the principal dichotomous analysis involved 5,717 T2D subjects, 3,345 with DKD. Promising association signals were evaluated in up to 26,827 subjects with T2D (12,710 with DKD). A combined T1D+T2D GWAS was performed using complementary data available for subjects with T1D, which, with replication samples, involved up to 40,340 subjects with diabetes (18,582 with DKD). Analysis of specific DKD phenotypes identified a novel signal near GABRR1 (rs9942471, P = 4.5 × 10−8) associated with microalbuminuria in European T2D case subjects. However, no replication of this signal was observed in Asian subjects with T2D or in the equivalent T1D analysis. There was only limited support, in this substantially enlarged analysis, for association at previously reported DKD signals, except for those at UMOD and PRKAG2, both associated with estimated glomerular filtration rate. We conclude that, despite challenges in addressing phenotypic heterogeneity, access to increased sample sizes will continue to provide more robust inference regarding risk variant discovery for DKD.